HIV protease inhibitors in gut barrier dysfunction and liver injury.
about
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity.Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
P2860
HIV protease inhibitors in gut barrier dysfunction and liver injury.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@ast
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@en
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@nl
type
label
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@ast
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@en
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@nl
prefLabel
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@ast
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@en
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@nl
P2093
P2860
P1476
HIV protease inhibitors in gut barrier dysfunction and liver injury.
@en
P2093
Huiping Zhou
Kesong Peng
Yunzhou Li
P2860
P356
10.1016/J.COPH.2014.07.008
P577
2014-08-06T00:00:00Z